#$%^&*AU2016202212B220180510.pdf#####ABSTRACT A solid dispersion transdermal drug delivery system comprising a therapeutic agent in a stable amorphous form and a combination polymeric stabilizing and dispersing agent having a hydrogen bond-forming functional group, and a method of manufacturing these systems is provided. The weight ratio of the combination polymeric stabilizing and dispersing agent to the therapeutic agent is also disclosed.WO 2009/158120 PCT/US2009/045739 1/3 11 FIG. 1 12 -10 13